SDIC Venture Capital

ounded in 2016, SDIC Venture Capital Co., Ltd. (SDICVC) is a fund management company founded by the State Development and Investment Corp. (SDIC), under a market driven governance structure. SDICVC currently manages four funds, with total asset under management at RMB 14 Billion. SDICVC puts into practice the marketization and industrialization of the nation’s scientific and technological achievements, focusing on an investment strategy of "serving the national innovation strategy and focusing on the transformation of scientific and technological achievements". SDICVC puts its expertise and experience to work to achieve its goals of policy orientation and return on investment, faithfully implementing the national development strategy, striving to realize the synergy between the government, the society and the market, realizing its positioning as "an ideal, trustworthy, respected, influential partner” and its role as a leading professional venture fund management institution.

Dechun Chen

VP

Zhong Guodong

VP

Meng Qian

VP

Li Ruge

CFO

Du Wenmin

VP

Yang Xiaohui

VP

Hua Zhang

CFO

145 past transactions

Asensing

Private Placement in 2020
Guangzhou Asensing Electronics CO., Ltd. engages in the development of inertial navigation and optoelectronic technology solutions. The company offers inertial and photoelectric sensing products, including vertical gyro, inertial measurement unit, attitude heading reference system, GPS/INS integrated navigation system, north finder, and other products. It also offers products based on fiber optic gyro, phase differential GPS/Beidou, and other applications. The company’s products are used for dynamic attitude angle, acceleration, heading measurement, motion control, and attitude compensation. It offers products to customers in aerospace, marine, and industrial sectors, as well as aircraft, ships, robots, and somatosensory terminals in China. The company was founded in 2014 and is based in Guangzhou, China.

Abogen Biosciences

Series A in 2020
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

TransThera Biosciences

Private Placement in 2020
TransThera Biosciences Co. Ltd. manufactures new chemical entity (NCE) oncology drugs for cardiovascular diseases. Its platform provides a novel business model to adapt internal research and open innovation. The company was founded in 2016 and is based in Nanjing, China. TransThera Biosciences Co. Ltd. operates as a subsidiary of PharmaBlock Sciences (Nanjing), Inc.

Aluksen Technology

Series B in 2022
Aluksen Technology is an industry leading semiconductor chip manufacturer specializing in optoelectronic technology. The R&D center is located in Silicon Valley, USA. We focus on the telecom, industrial and consumer electronics markets, and gradually form a marketing and service network with Shenzhen as the operation center and covering the global region. We will continue to innovate around customer needs and strive to provide high customers. Quality products and fast, professional technical support and services.

Yihui Information

Series B in 2022
Yihui Information is a high-tech enterprise with complete independent intellectual property rights

Zhishan Weixin Biotechnology

Series A in 2023
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.

Eucure Biopharma

Series A in 2016
Eucure (Beijing) Biopharma Co., Ltd discovers and develops immuno-oncology targeted antibodies. It offers antibody production, in vivo drug efficacy, and in vitro efficacy test. Its pipeline drugs include YH-001, YH-002, YH-003, YH-004, YH-005, YH-006, YH-007, and YH-008. The company was founded in 2016 and is headquartered in Beijing, China. As of August 31, 2020, Eucure (Beijing) Biopharma Co., Ltd operates as a subsidiary of Beijing Biocytogen Co., Ltd.

Beijing VDJBio Co., LTD.

Private Placement in 2020
Beijing VDJBio Co., LTD. offers research and development of monoclonal antibody drugs. The company researches the maturation mechanism of human antibodies to develop antibody drugs and antibody fusion protein drugs. Beijing VDJBio Co., LTD. was founded in 2011 and is based in Beijing, China.
Beijing CHAHO Communication Technology Co., Ltd. engages in the development and manufacture of communications products. Its product line includes super/ultra-high speed PCIe capture cards, high speed/high precision ADC and DAC daughter cards, multi-band down converters, frequency synthesizers, and smart RF modules. The company offers products in the areas of ultra-high-speed data transmission/acquisition, RF signal transmission/reception, high-speed analog-to-digital conversion, high-resolution digital/analog conversion, etc. It also provides technical support and after-sales maintenance services; and product related training services. The company serves defense departments, aerospace, shipbuilding, mobile communications, research institutes, radio and television, and others worldwide. The company is based in Beijing, China.

PhotonIC Technologies

Series C in 2019
PhotonIC Technologies is an optoelectronic integrated circuit chips provider. PhotonIC Technologies focus on designing, developing, and commercializing high-speed/low-power optoelectronic integrated chips for data center, 5G transmission, 3D ToF smart sensing and other fields.

Suzhou Abogen Biosciences Co., Ltd.

Private Placement in 2020
Suzhou Abogen Biosciences Co., Ltd. engages in developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases. The company was founded in 2019 and is based in Jiangsu, China.

SDIC CGOG Futures Co,LTD.

Merger/Acquisition in 2015
SDIC CGOG Futures Co,LTD. offers futures brokerage, consulting, and business training services. The company was formerly known as CGOG Futures Co Ltd. and changed its name to SDIC CGOG Futures Co,LTD. in August 2010. SDIC CGOG Futures Co,LTD. was founded in 1993 and is based in Shanghai, China. As per the transaction announced on May 13, 2010, SDIC CGOG Futures Co,LTD. operates as a subsidiary of SDIC Capital Holding Co., Ltd.

Sublue Ocean Science & Technology

Private Placement in 2018
Tianjin Deepinfar Ocean Technology Co., Ltd is a high-tech enterprise that focuses on the R&D, manufacture and sales of underwaterrobots and related core components. Founded in January 2013, the company islocated in the most rapid development zone, Tianjin Binhai New Area. They providethe produces and total solution to meet the requirements in field of Marine resourcedevelopment and marine environmental monitoring, products include autonomousunderwater vehicle (AUV), underwater glider (AUG), remote underwater vehicle(ROV) and other small underwater robots. Sublue is committed to being aleading company in underwater robot field and providing core technique to guaranteenational security and accelerate ocean resource development. The products of Sublue play important rolesin Marine economy development and marine equipment promoting. They are wildly usedin entertainment, rescue, salvage, submarine cleaning & maintenance, oceanengineering detection and operation, marine environment maintenance andinspection, marine scientific research and other fields.

Dakang Medical

Series E in 2022
Dakang Medical is a chain of independent blood purification medical service institutions. Dakang Medical is a company whose leading industries are medical investment, medical institution management, and brand operation services.

Nicezhuanye

Private Placement in 2019
Nicezhuanye offers O2O education service platform for education data analysis for high schools in Zhejiang and Shanghai. The company is based in China.

HQ Education

Series A in 2019
HQ Education is an O2O education service platform.

Biocytogen

Private Placement in 2020
Biocytogenan advanced biotechnology company located in Beijing's Economic and Technological Development Zone, was founded in November 2009 by a team of scientists who have multiple years’ experience developing animal models and operating Biocytogen USA. Biocytogen's goal is to become the leading gene targeted animal model and service supplier globally. Biocytogen efficiently integrates the advanced capabilities and resources available in both China and the USA. Biocytogen has established two excellent gene-targeting platforms. The first is a traditional ESC/HR platform that includes a unique gene targeting vector construction technology with an accurate micro-injection system and high germline transmission efficiency of C57BL/6 mouse embryonic stem cells (ESC).

DTStack

Series B in 2019
Kangaroo Cloud (quasi-unicorn enterprise) owns two digital technology subsidiaries, cloud technology and cloud technology, mainly for retail, finance, government, tourism, internet and other industries, providing digital stacks including DTinsight, data visualization, and data center solutions. Big data and cloud technology products and services, including solutions and cloud MSPs, help companies achieve digital transformation and promote industrial innovation and social progress.
Xiamen Sky Semiconductor Technology Co.Ltd. semiconductor system integration, process design, research and development, project verification, and mass production services. its products and services include wafer level chip scale package, through glass via (TGV), wafer-level integrated fan-out package (eGFO), wafer level passive device integration (WL-IPD), precision processing glass substrate, and low temperature bonding technology. The company was founded in 2018 and is based in Xiamen, China.

Biocytogen

Series B in 2017
Biocytogenan advanced biotechnology company located in Beijing's Economic and Technological Development Zone, was founded in November 2009 by a team of scientists who have multiple years’ experience developing animal models and operating Biocytogen USA. Biocytogen's goal is to become the leading gene targeted animal model and service supplier globally. Biocytogen efficiently integrates the advanced capabilities and resources available in both China and the USA. Biocytogen has established two excellent gene-targeting platforms. The first is a traditional ESC/HR platform that includes a unique gene targeting vector construction technology with an accurate micro-injection system and high germline transmission efficiency of C57BL/6 mouse embryonic stem cells (ESC).

Bangsun Technology

Series B in 2018
Hangzhou Bangsun Financial Information Technology Ltd. develops online payment security software to domestic Internet trading companies and online financial institutions. The company offers solution, such as banking solution, tripartite payment solution, bank card solution, credit card, securities, and e-government solutions. In addition, it provides products, including real time transaction anti-fraud, Internet credit, flow cube, machine learning system and model, device fingerprint, machine defense service, Internet risk data service, and anti-money laundering service. Hangzhou Bangsun Financial Information Technology Ltd. was founded in 2010 and is based in Hangzhou, China.

Realmax

Series A in 2017
Realmax Technology Limited is a high tech company in augmented reality (AR).

Gongda Satellite

Series A in 2021
Gongda Satellite is a commercial aerospace company that designs, manufactures on-orbit delivery commercial satellite products.

Bolean Tech

Private Placement in 2020
Bolean Tech, a technological innovation enterprise, develops and manufactures the industrial control systems of offensive and defensive technology research and security. The company also provides customers with product customization, security consulting, threat assessment, equivalent security construction, personnel training, and system operation services. It serves customers in various industries, including power, oil, tobacco, and water in China and internationally. The company is based in Hangzhou, China.

Jinyi New Material

Venture Round in 2021
Ginet New Material is a technology company providing R&D and production of inorganic non-metallic powder new material application solutions.

Bangsun Technology

Private Placement in 2019
Hangzhou Bangsun Financial Information Technology Ltd. develops online payment security software to domestic Internet trading companies and online financial institutions. The company offers solution, such as banking solution, tripartite payment solution, bank card solution, credit card, securities, and e-government solutions. In addition, it provides products, including real time transaction anti-fraud, Internet credit, flow cube, machine learning system and model, device fingerprint, machine defense service, Internet risk data service, and anti-money laundering service. Hangzhou Bangsun Financial Information Technology Ltd. was founded in 2010 and is based in Hangzhou, China.

Allist Pharmaceuticals

Series A in 2019
Shanghai Allist Pharmaceuticals Co., Ltd. engages in the discovery, development, and commercialization of pharmaceutical products for human health in China and internationally. It offers generic and branded pharmaceuticals for the treatment of cardiovascular, acid related, and cancer diseases. The company was founded in 2004 and is based in Shanghai, China.

WM Motor

Series D in 2020
WM Motor is an automotive company that designs, manufactures, develops, and markets energy and battery-operated vehicles. It provides energy vehicle products and travel solutions to its customers. The company aims to conserve electronic vehicles in addition to intelligent data hardware, enabling consumers to utilize smart cars that are efficient and energy conserving. WM Motor’s products are built with three core technologies, the Living Motion electric powertrain, the Living Pilot intelligent driving assistance system, and the Living Engine operating system, which offers industry-leading smart connectivity and interactive features.

Biocytogen

Private Placement in 2019
Biocytogenan advanced biotechnology company located in Beijing's Economic and Technological Development Zone, was founded in November 2009 by a team of scientists who have multiple years’ experience developing animal models and operating Biocytogen USA. Biocytogen's goal is to become the leading gene targeted animal model and service supplier globally. Biocytogen efficiently integrates the advanced capabilities and resources available in both China and the USA. Biocytogen has established two excellent gene-targeting platforms. The first is a traditional ESC/HR platform that includes a unique gene targeting vector construction technology with an accurate micro-injection system and high germline transmission efficiency of C57BL/6 mouse embryonic stem cells (ESC).

Tianfu

Series B in 2021
Nanjing Tianfu Software Co., Ltd. develops custom software solutions for various industries, such as turbomachinery, hydraulic construction, automotive, aerospace, and shipbuilding. The company founded in 2011 and is based in Nanjing, China.

TZAUTO

Private Placement in 2020
TZAUTO is committed to becoming the leading enterprise in promoting intelligent manufacturing in China's electronic circuit industry and semiconductor industry, and helping "Made in China 2025". The company has long focused on the development and innovation of equipment automation technology, providing industrial solutions for the production of full-process intelligent manufacturing, independent independent research and development capabilities of standard SECS/GEM communication protocols and non-standard equipment communication protocols, and obtained relevant patent certification.

DigiHuman

Post in 2018
Shandong Digihuman Technology Co.,Inc designs and develops digital human body system and application software solutions. The company offers China Digihuman Anatomy System, digital medical image processing, human body big data, and digital medical teaching platform. It offers various solutions, including medical education, life science education, clinical treatment, Digihuman cloud platform. The company serves the medicine, clinics, science popularization, aviation, and military fields. Shandong Digihuman Technology Co.,Inc was formerly known as Shandong Yichuang Electronics Co., Ltd. and changed its name to Shandong Digihuman Technology Co.,Inc in August 2015. The company was founded in 2002 and is based in Jinan City, China.

Robotleo

Series B in 2018
Robotleo manufactures robots for domestic use. The company was founded in 2014 and is based in Beijing, China.

ZETTASTONE

Angel Round in 2018
Beijing Zettastone Technology Co., Ltd. is a solid state hard disk company based in Beijing, China.

Zhiyi Pharmaceutics

Series B in 2020
Zhiyi Pharmaceutics Inc., a biopharmaceutical company, is engaged in research and development of NGPs (next-generation probiotics) and LBPs (live biotherapeutics). The company’s products include SK08, TP2, ZY19, and SK09. Its products can be used for treating gastrointestinal disorders. Zhiyi Pharmaceutics Inc. was founded in 2013 and is headquartered in Guangzhou, China.

Casiris

Series D in 2019
Casiris Vision is a limited liability company jointly invested by the Institute of Physics and Chemistry of the Chinese Academy of Sciences, Hangzhou Economic and Technological Development Zone, venture capital and technical team. The company is committed to R&D and production challenges. A pure laser display product with a human visual limit. In 2016, it was recognized as a national high-tech enterprise, a high-tech enterprise in Hangzhou, a technology-based enterprise in Zhejiang and Hangzhou Economic and Technological Development Zone. At present, Zhongke Aurora has 5,500 square meters of automated light source and complete machine production line, providing laser light source applications to home theater, engineering projection, film and lighting engineering complete solutions.
Zhejiang Bluetron Industrial Internet Information Technology Co., Ltd. is located in Ningbo, Zhejiang, China and is part of the Computer Systems Design and Related Services Industry. There are 4 companies in the Zhejiang Bluetron Industrial Internet Information Technology Co., Ltd. corporate family.

OMNI

Series B in 2017
Shanghai OMNI Pharmaceutical Technology Co., Ltd. researches, develops, and manufactures respiratory pharmaceutical products in China. It offers contract manufacturing organizations (CMO) and clinical research organizations (CRO) services of difficult dosage forms. The company was founded in 2006 and is based in Shanghai, China.

Everbright Photonics

Series C in 2020
Everbright Photonics is a Smart Hardware company.

Well-healthcare Technologies

Private Placement in 2020
Well-healthcare Technologies is a high-tech company that develops and produces health monitoring, industrial monitoring, public safety monitoring, environmental monitoring and food monitoring sensors based on IoT technology; and new medical diagnostic products and research services. The company's core technologies in the sensor field include low-energy sensing materials and sensing systems, electronic nose systems that recognize complex gases, and wearable sensors based on flexible materials. The sensors it develops will also provide medical institutions with rapid microbiological analysis, drug susceptibility testing, drug screening and other solutions.

Feilongyu

Angel Round in 2017
Guizhou Feilongyu Industrial Group Co., Ltd. engages in the production and sales of water for consumption. The company was founded in 1993 and is based in Guiyang, China.

PhotonIC Technologies

Private Placement in 2019
PhotonIC Technologies is an optoelectronic integrated circuit chips provider. PhotonIC Technologies focus on designing, developing, and commercializing high-speed/low-power optoelectronic integrated chips for data center, 5G transmission, 3D ToF smart sensing and other fields.

Changhong Intelligent

Private Placement in 2018
Changhong Intelligent is based in Yancheng, China.
Wuhan GreeNet Information Service Co., Ltd. offers carrier-grade network and security equipment and solutions. The company offers Super Intelligent Network Element (SINE), a networking equipment that integrates the functions of edge access, edge computing, edge storage, deep packet inspection (DPI), and network security. It offers security solutions, such as Wireline Analytics that provides data support services for pipelines and network digitalization; 4G Analytics offers end-to-end data of network quality indicators; VoLTE Analytics deployed in the voice over LTE (VoLTE) service operators, and can monitor the network data and offer big data analysis capability in combination with software and hardware; IoT Analytics deployed in the long term Evolution (LTE) network and provides big data analysis; Internet Anti-spoofing System provides alerts and manages phishing uniform resource locators (URL); and Smart Data cloud warehouse provides cloud data warehouse service that enables users to analyze data. Wuhan GreeNet Information Service Co., Ltd. was founded in 2003 and is based in Wuhan, China with additional locations in Beijing, Guangzhou, Nanjing, Shenzhen, Shanghai, and Hangzhou, China.

Time Speed

Series B in 2021
Time Speed ​​is a radio frequency integrated circuit developer, which can provide monolithic microwave integrated circuits, radio frequency integrated circuits, gallium arsenide gallium nitride power amplifier chips, low noise amplifier chips, and radio frequency front-end module chips for users in the 4G/5G communications market. And other products.

Guangdong Xinjuneng

Venture Round in 2021
Xinjuneng Semiconductor is a semiconductor device manufacturer integrating design, research and development, and production. It is mainly oriented to the new energy vehicle and power semiconductor application market, providing users with power semiconductor packaging, modules and other products.

Cambricon Technologies

Series B in 2018
Cambricon Technologies Corporation Limited creates core processor chips for various types of intelligent cloud servers, intelligent edge devices, and intelligent terminals. It offers terminal intelligent processor IPs, smart accelerator cards, and edge artificial intelligence acceleration cards; and Cambricon NeuWare, a software development platform for its cloud, edge, and end intelligent processor products. The company was founded in 2016 and is based in Beijing, China.

Innovent Biologics

Series D in 2016
Innovent Biologics, Inc. is a privately held biopharmaceutical company that is dedicated to the development and manufacturing of monoclonal antibodies to be marketed in China and elsewhere around the world. Innovent is funded by the venture arm of Fidelity, which is a major investment firm in the US, Lilly Ventures, and Suzhou bioBay. The registered capital is 30Million US Dollars. The founders and senior management team of Innovent have over 70 years of combined work experience in the discovery, development and manufacture of biologics in the US, Europe and worldwide and were involved in the launch of such products as Bexxar, Conbercept, Natrecor, Oncorine, Recombivax HB, and others.

Biostar Technologies

Series B in 2019
Beijing Biostar Technologies, Ltd. was incorporated in Haidian Park, Zhongguancun Science and Technology Park, Beijing, in July 2002. The national high-tech led by the team of Chinese scientists in the United States led by Dr. Tang Li and Dr. Qiu Rongguo. The company, focusing on biomedical development, technology and transfer of anti-tumor small molecule chemical drugs, and technical service consulting, pioneered the creation of new anti-cancer drugs for epothilone in China, and its technology is at the international advanced level.

Air Touch

Series C in 2022
Air Touch is a Fvss dedicated to RF and microwave integrated circuit design companies, providing solutions for chips, modules, algorithms, software and even intelligent terminals. Become the world's leading supplier of microwave and millimeter wave radar chips and solutions. The technology is derived from the miniature millimeter wave short-range radar detector in the military industry. It has applied for more than 10 invention patents and has strong financial strength to support the company's sustainable development. The company dares to adopt first-class technical solutions to locate and develop world-class technology. Chip products.

Essence Securities Company Limited, Textile Assets

Merger/Acquisition in 2015
As per the transaction announced on June 23, 2015, Essence Securities Company Limited, Textile Assets was acquired by SDIC Capital Holding Co., Ltd..

SVOLT

Series B in 2021
Svolt Energy Technology Co., Ltd. is a high-tech new energy company that specializes in energy technology, including electric vehicle battery (EVB) materials, cells, modules, PACK, BMS, energy storage system (ESS) and solar energy R&D and manufacturing. Headquartered in Wuxi, Jiangsu, SVOLT plans for 7 R&D centers around the globe, with four currently in operation, in Baoding, Korea, Shanghai and India, and three are under construction in the US, Japan and Wuxi. Domestically, SVOLT’s factory is under construction in Changzhou, Jiangsu, which will be operational by the end of 2019 with SOP in February 2020, and will have a capacity of 12GWh in 2020. Roadmap: SVOLT is pioneering the introduction of prismatic stacking batteries, making it the world’s first high-speed stacking prismatic battery maker. SVOLT aims to finish stacking one cell in 0.25 seconds in one single station. In contrast to the same type of winding process, the energy density of SVOLT stacking batteries improves 5%, the cycle life improves 10% and the cost reduces 15%.

Everbright Photonics

Series B in 2018
Everbright Photonics is a Smart Hardware company.

Cambricon Technologies

Private Placement in 2018
Cambricon Technologies Corporation Limited creates core processor chips for various types of intelligent cloud servers, intelligent edge devices, and intelligent terminals. It offers terminal intelligent processor IPs, smart accelerator cards, and edge artificial intelligence acceleration cards; and Cambricon NeuWare, a software development platform for its cloud, edge, and end intelligent processor products. The company was founded in 2016 and is based in Beijing, China.

Aucta Pharmaceuticals

Series A in 2021
Provider of a drug development platform intended to improve drug delivery and develop novel and niche generic medical products. The company's drug development platform is poorly water soluble, features controlled release and specializes in central nervous system and oncology compound, enabling pharmaceuticals companies to develop drugs and drug-based products based on patient compliance.

Jiangsu Safe Pharmaceutical Co., Ltd.

Private Placement in 2020
Jiangsu Safe Pharmaceutical Co., Ltd. operates as a pharmaceutical company. The company manufactures capsules, tablets, creams, and suppositories. The company is based in Wuxi, China. As of November 30, 2016, Jiangsu Safe Pharmaceutical Co., Ltd. operates as a subsidiary of WuXi AppTec Co., Ltd.

MabPlex International

Private Placement in 2019
MabPlex International Ltd provides contract development and manufacturing of biopharmaceuticals including, monoclonal antibodies (mAbs), recombinant proteins, Antibody Drug Conjugates (ADCs) and bispecifics. It offers customized mammalian cell medium, cell banking, monoclonal antibodiy active pharmaceutical ingredient (API) manufacturing, and biologics and ADC fill and finish manufacturing. The company was founded in 2013 and is based in Yantai, China with an additional office in Fremont, California.

Bo Shi Ran

Venture Round in 2021
Bo Shi Ran is a cotton harvester that provides mechanized solutions for cotton planting, integrating R&D, production, sales, and service.

G7

Private Equity Round in 2022
G7 has an installation base of 800,000 cargo vehicles throughout China. Through its proprietary hardware devices, the company is able to compile data for logistics companies and drivers on location, route optimization, fuel consumption, and cargo status (temperature, humidity, etc).

JianAn Agro-pastoral

Private Placement in 2020
JianAn Agro-pastoral offers logistics solutions for the agriculture and animal husbandry. The company was founded in 2010 and is based in Suqian, China.

Shanghai Linda Biopharmaceutical Co., Ltd.

Private Placement in 2020
Shanghai Linda Biopharmaceutical Co., Ltd. develops anti tumor drugs. The company was founded in 2017 and is based in Shanghai, China.

Sublue Ocean Science & Technology

Private Placement in 2020
Tianjin Deepinfar Ocean Technology Co., Ltd is a high-tech enterprise that focuses on the R&D, manufacture and sales of underwaterrobots and related core components. Founded in January 2013, the company islocated in the most rapid development zone, Tianjin Binhai New Area. They providethe produces and total solution to meet the requirements in field of Marine resourcedevelopment and marine environmental monitoring, products include autonomousunderwater vehicle (AUV), underwater glider (AUG), remote underwater vehicle(ROV) and other small underwater robots. Sublue is committed to being aleading company in underwater robot field and providing core technique to guaranteenational security and accelerate ocean resource development. The products of Sublue play important rolesin Marine economy development and marine equipment promoting. They are wildly usedin entertainment, rescue, salvage, submarine cleaning & maintenance, oceanengineering detection and operation, marine environment maintenance andinspection, marine scientific research and other fields.

ECTEK

Post in 2017
Changzhou ECTEK Automotive Systems CO., Ltd researches, develops, manufactures, and sells electrical automotive products. The company offers vehicle control systems, test bench and control systems, electronic control unit (ECU) test systems, and diesel electric control systems. Changzhou ECTEK Automotive Systems CO., Ltd supplies its products to marine, locomotive, construction machinery, and other power industries. The company was founded in 2005 and is based in Changzhou, China.

BGI Tech

Post in 2021
Shenzhen Huada Gene Technology Co. Ltd. operates as a biotech development company. The Company provides bioinformatics testing, genetic testing, agricultural genomics researching, proteomics researching, and other services. Shenzhen Huada Gene Technology conducts business in China.

Suzhou Mega Plastics Co., Ltd.

Private Placement in 2020
Suzhou Mega Plastics Co., Ltd. manufactures and sells polymer compounds. The company offers medical grade PVC granules, general grade PVC granules, low smoke halogen-free granules, and TPE granules. Its products are used for medical devices, automotive application, marine cable and wire, communication cable and wire, green energy cable and wire, rail transit cable and wire, applicances cable and wire, and for general application. The company was founded in 2001 and is based in Suzhou, China

BYD

Venture Round in 2020
BYD is engaged in the research, development, manufacture, and distribution of automobiles, secondary rechargeable batteries, and mobile phone components. The company operates its businesses primarily through its secondary rechargeable battery business that provides lithium-ion batteries and nickel batteries which are applied in mobile phones, digital cameras, electric tools, electric toys, and other portable electronic devices; mobile phone components and assembly businesses which offer casings, keypads, liquid crystal display (LCD) modules, cameras, flexible circuit boards, chargers, and mobile phone design and assembly services; and automobile business which provides automobiles, including G6, S6, and other series.

Bangsun Technology

Series C in 2019
Hangzhou Bangsun Financial Information Technology Ltd. develops online payment security software to domestic Internet trading companies and online financial institutions. The company offers solution, such as banking solution, tripartite payment solution, bank card solution, credit card, securities, and e-government solutions. In addition, it provides products, including real time transaction anti-fraud, Internet credit, flow cube, machine learning system and model, device fingerprint, machine defense service, Internet risk data service, and anti-money laundering service. Hangzhou Bangsun Financial Information Technology Ltd. was founded in 2010 and is based in Hangzhou, China.

Peijia Medical

Private Placement in 2019
“Peijia Medical” was established in early 2012, by returned oversea Chinese expert in professional medical device industry, providing R&D and production of interventional medical products. The company with register capital of RMB¥30 million is located in Suzhou Industrial Park, Suzhou city of Jiangsu Province. The city of Suzhou is famously named as "earthly paradise in China" and the Industrial Park beside Jinji Lake is called as “new paradise of venture capital investment”. The company covers an area of about 10000 sqm, within which laboratory and controlled environment room taking about 1800 sqm. The company has state of the art interior design with western high tech modern style infused with Suzhou oriental garden style. The office building, laboratory, and controlled environment production rooms are fully put into operation now.

Enmotech

Series B in 2017
Enmotech (Beijing) Information Technology Co., Ltd. provides solutions and professional services for data/database systems and related areas. The company’s products and services include security, performance optimization, integration, and others. It also offers technical services, such as distributed architecture, high availability disaster recovery, SQL audit, operation and maintenance, performance monitoring, professional training, and data model optimization. In addition, the company provides software that comprise Bethune, an IT system health automated inspection platform; zCloud database cloud service management platform; SQM – SQL quality control platform; zData database machine; and MyData, an automated operation and maintenance management platform. It serves customers in financial services, communication operation, energy transportation, government/public utility, and manufacturing/trade markets. The company was founded in 2009 and is based in Beijing, China.

Biocytogen

Series D in 2020
Biocytogenan advanced biotechnology company located in Beijing's Economic and Technological Development Zone, was founded in November 2009 by a team of scientists who have multiple years’ experience developing animal models and operating Biocytogen USA. Biocytogen's goal is to become the leading gene targeted animal model and service supplier globally. Biocytogen efficiently integrates the advanced capabilities and resources available in both China and the USA. Biocytogen has established two excellent gene-targeting platforms. The first is a traditional ESC/HR platform that includes a unique gene targeting vector construction technology with an accurate micro-injection system and high germline transmission efficiency of C57BL/6 mouse embryonic stem cells (ESC).

Ningbo Sansheng Biological Technology Co., Ltd.

Private Placement in 2019
Ningbo Sansheng Biological Technology Co., Ltd. supplies livestock reproductive hormones. The company was founded in 2012 and is based in Ningbo, China.

Dalian Sansheng Technology Development Co., Ltd.

Private Placement in 2019
Dalian Sansheng Technology Development Co., Ltd. manufactures dental implants. Dalian Sansheng Technology Development Co., Ltd. was founded in 2011 and is headquartered in Liaoning Province, China.

Viiyong

Series B in 2022
Viiyong is a manufacturer of multi-layer ceramic chip capacitors.

XuanZhu Pharma

Series A in 2020
Shandong Xuanzhu Pharmaceutical Technology Co., Ltd. is engaged in pharmaceutical research and development. The company conducts pharmacodynamics and pharmacokinetic analysis,a process in which it screens, designs and matches chemical compounds, analysing the effect of drugs on the human body and their absorption rates. The company is based in China.

OMNI

Series C in 2017
Shanghai OMNI Pharmaceutical Technology Co., Ltd. researches, develops, and manufactures respiratory pharmaceutical products in China. It offers contract manufacturing organizations (CMO) and clinical research organizations (CRO) services of difficult dosage forms. The company was founded in 2006 and is based in Shanghai, China.

Huitongda

Series E in 2021
HUITONGDA Network Co., Ltd. provides online merchandising and marketing to retail outlets. It helps offline stores sell goods via e-commerce and also provides infrastructure for e-commerce retailers to sell to rural residents. The company sells air-conditioning, color TV, refrigerator, and washing machine to rural customers. HUITONGDA Network Co., Ltd. was founded in 2008 and is based in Nanjing, China. The company operates as a subsidiary of Jiangsu Five Star Appliance Co., Ltd.

Hangzhou Daishu Technology Co., Ltd.

Private Placement in 2019
Hangzhou Daishu Technology Co., Ltd. operates and maintains data center platform. The company provides data visualization service; data center solutions; O and M Mid-Taiwan solution; and Number Stack (DTinsight). Hangzhou Daishu Technology Co., Ltd. was founded in 2015 and is headquartered in Hangzhou, China.

MoonBiotech

Series C in 2021
Guangzhou Based Healthcare Start up.

Biostar Technologies

Private Placement in 2019
Beijing Biostar Technologies, Ltd. was incorporated in Haidian Park, Zhongguancun Science and Technology Park, Beijing, in July 2002. The national high-tech led by the team of Chinese scientists in the United States led by Dr. Tang Li and Dr. Qiu Rongguo. The company, focusing on biomedical development, technology and transfer of anti-tumor small molecule chemical drugs, and technical service consulting, pioneered the creation of new anti-cancer drugs for epothilone in China, and its technology is at the international advanced level.
Beijing Yunzhong Rongxin Network Technology Co., Ltd. provides instant messaging cloud service. The company is based in Beijing, China.

Biocytogen

Series C in 2018
Biocytogenan advanced biotechnology company located in Beijing's Economic and Technological Development Zone, was founded in November 2009 by a team of scientists who have multiple years’ experience developing animal models and operating Biocytogen USA. Biocytogen's goal is to become the leading gene targeted animal model and service supplier globally. Biocytogen efficiently integrates the advanced capabilities and resources available in both China and the USA. Biocytogen has established two excellent gene-targeting platforms. The first is a traditional ESC/HR platform that includes a unique gene targeting vector construction technology with an accurate micro-injection system and high germline transmission efficiency of C57BL/6 mouse embryonic stem cells (ESC).

Immunochina

Private Placement in 2020
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.